(Q34189203)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

M Adams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Fiander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Jasani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Navabi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Lipetz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A S Evans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Mason

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

17-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

2549-2556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Papillomaviruses in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

A case-control study of cervical cancer screening in north east Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Complications of smallpox vaccination, 1968.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Use of recombinant vaccinia viruses to examine cytotoxic T lymphocyte recognition of individual viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900488-6

7 January 2021

10.1016/S0264-410X(00)00488-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257391%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference